FindTrial
Sign In

MTM

OTHER5 trials

Sponsors

Genelex Corporation, University of Minnesota, HealthEast Care System, University of North Carolina, Chapel Hill, University of Wisconsin, Madison

Conditions

CYP2D6 PolymorphismCytochrome P450 CYP2C19 Enzyme DeficiencyCytochrome P450 CYP2C9 Enzyme DeficiencyCytochrome P450 CYP2D6 Enzyme DeficiencyDiabetesDiabetes Mellitus, Type 2Diabetes Type 2Drug Metabolism, Poor, CYP2C19-RELATED

Unknown Phase

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
CompletedNCT02428660
Genelex CorporationCYP2D6 Polymorphism, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency +6
Start: 2015-02-28End: 2017-02-28Updated: 2017-02-23
Program on Lung Cancer Screening and Tobacco Cessation
CompletedNCT02597491
University of MinnesotaSmoking
Start: 2015-12-31End: 2022-09-30Target: 1000Updated: 2023-04-25
Outcomes Study of MTM in a Medicare ACO
CompletedNCT02875925
HealthEast Care SystemHypoglycemia, Pain
Start: 2015-12-31End: 2017-12-31Updated: 2018-02-27
Food As MedicinE for Diabetes
Active, not recruitingNCT04828785
University of North Carolina, Chapel HillDiabetes Mellitus, Type 2
Start: 2021-07-02End: 2026-03-31Target: 200Updated: 2025-09-24
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
RecruitingNCT05912647
University of Wisconsin, MadisonDiabetes, Diabetes Type 2
Start: 2024-02-03End: 2027-12-01Target: 376Updated: 2026-02-24

Related Papers

Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening
JAMA Network Open2023-08-2423 citations
Medically tailored meals for food insecurity and type 2 diabetes: Protocol for the Food as Medicine for Diabetes (FAME-D) trial.
2022-12-056 citations
Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients
Journal of Managed Care & Specialty Pharmacy2018-11-2749 citations